Skip to Content

KRC500 KRC500 (Cefaclor 500 mg)

Pill imprint KRC500 KRC500 has been identified as Cefaclor 500 mg.

Cefaclor is used in the treatment of bronchitis; urinary tract infection; upper respiratory tract infection; bladder infection; tonsillitis/pharyngitis (and more), and belongs to the drug class second generation cephalosporins. There is no proven risk in humans during pregnancy. Cefaclor 500 mg is not a controlled substance under the Controlled Substance Act (CSA).

Cefaclor 500 mg KRC500 KRC500
Cefaclor 500 mg KRC500 KRC500
Discount Card Promo
KRC500 KRC500
500 mg
Blue & Orange
Prescription only
Drug Class:
Second generation cephalosporins
Pregnancy Category:
B - No proven risk in humans
CSA Schedule:
Not a controlled drug
Alvogen, Inc.
National Drug Code (NDC):
Inactive Ingredients:
magnesium stearate
lactose monohydrate
magnesium silicate
sodium glycolate
titanium dioxide
FD&C Blue No. 1
FD&C Red No. 3
FD&C Yellow No. 6
FD&C Red No. 40
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
61442-0172 Carlsbad Technology, Inc.
60429-0702 Golden State Medical Supply (repackager)

Note: Inactive ingredients may vary.

More info Print Imprint Search

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2016, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.